GlucoTrack, Inc. Common Stock (GCTK)
GlucoTrack, Inc. (GCTK) is a healthcare technology company specializing in non-invasive glucose monitoring solutions. The company develops devices aimed at providing painless and convenient blood sugar measurements for individuals with diabetes. Their proprietary technology utilizes a combination of electromagnetic, thermal, and cardio signals to assess glucose levels without the need for blood samples.
Company News
Glucotrack, a medical technology company, reported strong progress in 2024, including advancing its continuous blood glucose monitoring technology from preclinical to clinical stage, strengthening its leadership team, and securing funding to support its growth plans.
Shares of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults with desmoid tumors. SpringWorks Therapeutics shares rose 14.4% to $23.77 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers SaverOne 2014 Ltd (NASDAQ: SVRE) shares rose 74.8% to $0.7389 in pre-market trading. SaverOne announced withdrawal of proposed public offering due to market conditions. ESGL Holdings Limited (NASDAQ: ESGL) shares rose 54.3% to $1.38 in pre-market trading after the company disclosed a multi-year contract renewal with Singapore Refining Company Private Limited. Heart Test Laboratories, Inc. (NASDAQ: HSCS) rose 27.5% to $0.2735 in pre-market trading. Heart Test Laboratories 13G filing showed Icahn School of Medicine at Mount Sinai ("ISMMS") EIN 13-6171197 reported a 9.9% stake in the company, as of Nov. 16, 2023. RedHill Biopharma Ltd. (NASDAQ: RDHL) shares surged 21% to $1.21 in pre-market trading. Redhill Biopharma shares jumped 217% ...
Can these tips help you make money with penny stocks in 2023? The post Spotting Winning Penny Stocks: 3 Top Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.